Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gloria
Gloria Buley, Shokan, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090009896 | Mirror For Improved Visibility Of Danger Zone Area On Right Side Of School Buses - The present invention relates to a mirror and mirror system which can be used in connection with large vehicles, such as school buses, to provide the driver of such vehicles with the ability to view the entire side of the vehicle. While such vehicles currently include side view mirrors attached to the front of the vehicle, these mirrors contain blind spots, such as the area immediately in front of the rear wheel of the vehicle. The current invention overcomes such blind spots by attaching a second mirror to the rear portion of the vehicle that provides a forward view from the rear of the vehicle, including a view of such blind spots. Such front and rear mirrors may be aligned so that the view of the rear mirror is portrayed within the view of the front mirror. As such, the present invention provides the driver with a complete view of the passenger side of the vehicle. | 01-08-2009 |
Gloria Calderita Lucas, Tres Cantos ES
| Patent application number | Description | Published |
|---|---|---|
| 20110190164 | CHIMERIC FUSION PROTEINS AND VIRUS LIKE PARTICLES FROM BIRNAVIRUS VP2 - The field of the invention refers to chimeric Virus Like Particles (VLP) derived from Birnavirus chimeric VP2 protein. In particular, the invention refers to chimeric VP2 fusion proteins which incorporate insertions and/or substitutions with one or more amino acids or particular peptide of interest while maintaining the capacity to assemble in the form of VLP. The invention identifies particular insertion and/or substitutions sites within VP2 P loop regions and outside said P loop regions. The invention also incorporates methods for the identification of preferred insertion and substitution sites within VP2 for the incorporation of particular amino acids and peptides of interest. The resulting chimeric VLP are of interest in the design of therapeutic and prophylactic vaccines as well as in the design of drug delivery systems, carriers for DNA and RNA in gene therapy, as targeted agents, in the development of antitoxins, and as diagnostic reagents. | 08-04-2011 |
| 20120269844 | VACCINES FOR THE TREATMENT OF NEOPLASIAS FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING ANTIGENS OF THE HUMAN PAPILLOMAVIRUS - The invention relates to therapeutic vaccines for the treatment of neoplasias caused by the human papillomavirus (HPV). In particular, the vaccines of the present invention are formed by chimeric virus-like capsids of birnavirus containing papillomavirus antigens. | 10-25-2012 |
Gloria Cheal, Beaconsfield CA
| Patent application number | Description | Published |
|---|---|---|
| 20090176827 | MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF - The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide, methods of preparing crystalline maleate salt forms, the associated compounds, and pharmaceutical compositions containing the same. The maleate salts are useful in treating cancers, particularly those affected by kinases of the epidermal growth factor receptor family. | 07-09-2009 |
| 20090264648 | SYNTHESIS OF PYRAZOLES - The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system. | 10-22-2009 |
| 20100016639 | PRODUCTION OF CHIRALLY PURE AMINO ALCOHOL INTERMEDIATES, DERIVATIVES THEREOF, AND USES THEREOF - A method of selectively preparing a chiral 2S-amino alcohol useful in preparation of an amide sulfonated or acylated with alkyl, substituted aryl or substituted heteroaryl is described. The method involves reacting a di-tert-butyl diazene-1,2-dicarboxylate with a (4S)-4-benzyl-3-[(S)-trifluoromethyl-alkyl substituted alkanoyl]-1,3-oxazolidin-2-one to afford a di-tert-butyl 1-(1S,2S)-([(4S)-4-benzyl-2-oxo-1,3-oxazolidine-3-yl]-carbonyl}-trifluoromethyl-alkyl substituted alkyl)hydrazine-1,2-dicarboxylate. This dicarboxylate is then reduced to yield di-tert-butyl 1-(1S,2S)-[trifluoromethyl-alkyl substituted alkyl]hydrazine-1-(hydroxymethyl)-1,2-dicarboxylate. The resulting product is deblocked with an acid to yield the acid addition salt of (2S,3S)-trifluoro-hydrazino-methyl alkan-1-ol. The acid addition salt of (2S,3S)-trifluoro-2-hydrazino-methyl alkan-1-ol is hydrogenated in the presence of a suitable metal catalyst to yield the amino alcohol (2S,3S)-2-amino-trifluoro-methyl alkan-1-ol HCl. | 01-21-2010 |
| 20110313166 | MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF - The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide, methods of preparing crystalline maleate salt forms, the associated compounds, and pharmaceutical compositions containing the same. The maleate salts are useful in treating cancers, particularly those affected by kinases of the epidermal growth factor receptor family. | 12-22-2011 |
| 20120289545 | Maleate Salts of (E)-N--4-(Dimethylamino)-2-Butenamide and Crystalline Forms Thereof - The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide, methods of preparing crystalline maleate salt forms, the associated compounds, and pharmaceutical compositions containing the same. The maleate salts are useful in treating cancers, particularly those affected by kinases of the epidermal growth factor receptor family. | 11-15-2012 |
Gloria Coruzzi, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090083876 | Methods of affecting nitrogen assimilation in plants - Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCA1, GLK1 or bZIP1, operably linked to a plant-specific promote, wherein the CCA1, GLK1 or bZIP1 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA1, GLK1 or bZIP1 are provided. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein. | 03-26-2009 |
| 20090094711 | Methods of affecting plant growth with microRNA - Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding microRNA167 (miR167), or precursor thereof, operably linked to a plant pericycle-specific promote, wherein the miR167 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In some embodiments, the transgenic plant has an improved agronomic or nutritional characteristic when cultivated in nitrogen-rich conditions as compared to a wild type plant cultivated in the same conditions. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein. | 04-09-2009 |
| 20110179519 | Methods of Affecting Nitrogen Assimilation In Plants - Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCA1, GLK1 or bZIP1, operably linked to a plant-specific promote, wherein the CCA1, GLK1 or bZIP1 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA1, GLK1 or bZIP1 are provided. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein. | 07-21-2011 |
| 20120151635 | METHODS OF AFFECTING NITROGEN ASSIMILATION IN PLANTS - Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCA1, GLK1 or bZIP1, operably linked to a plant-specific promote, wherein the CCA1, GLK1 or bZIP1 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA1, GLK1 or bZIP1 are provided. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein. | 06-14-2012 |
Gloria Crespo Sueiro, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20110118343 | Antitumoral Macrolides - Antitumoral compounds of general formula I: | 05-19-2011 |
Gloria Dicapua, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20100041579 | PARTICULATE BLEACHING COMPOSITION COMPRISING ENZYMES - Particulate bleach additive composition containing enzymes, which can be used to bleach fabrics in conjunction with a conventional granular or liquid laundry detergent. | 02-18-2010 |
| 20100327225 | PACKAGED PARTICULATE BLEACHING COMPOSITIONS - The present invention relates to a packaged particulate bleaching composition the composition comprising: | 12-30-2010 |
| 20100331229 | BLEACHING COMPOSITIONS COMPRISING A PERFUME DELIVERY SYSTEM - Particulate bleaching composition comprising a bleaching system, as a first essential component, which comprises oxygen bleach, a bleach activator and a perfume delivery system. Such perfume delivery system is preferably chosen among an amine reaction product containing perfume or an encapsulated perfume made of starch. | 12-30-2010 |
Gloria Freixas Pascual, Tarragona ES
| Patent application number | Description | Published |
|---|---|---|
| 20130045998 | PROCESS FOR PREPARING RUFINAMIDE INTERMEDIATE - The present invention refers to an improved method for the preparation of compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid substantially free of its 3H-I isomer. The invention also refers to the use of said intermediate for the preparation of Rufinamide and for obtaining a new polymorphic form of Rufinamide, designed as Form R-5. The invention also refers to said new polymorph of Rufinamide, and to the composition containing it and its use as medicament. The new polymorph of Rufinamide shows good stability and appropriate physico-chemical properties for its manipulation on industrial scale. Polymorph Form R-5 will be suitable to use as pharmaceutical for the treatment of convulsions, especially for the treatment of epilepsy. | 02-21-2013 |
Gloria Garavito, Puerto CO
| Patent application number | Description | Published |
|---|---|---|
| 20120107335 | Synthetic Oligopeptides Designed From Mite Cysteine Proteases and Methods for the Production of - The invention refers to the design, synthesis and evaluation of 6 synthetic oligopeptides, that have not been previously described, designed from the T and B epitopes of allergens of group I of intradomiciliary mites of the species | 05-03-2012 |
Gloria González Aseguinolaza, Pamplona Navarra ES
| Patent application number | Description | Published |
|---|---|---|
| 20110262399 | PORPHOBILINOGEN DEAMINASE GENE THERAPY - The present invention relates to nucleotide sequences coding for human porphobilinogen deaminase that are optimised for higher expression in mammalian cells. The invention further relates to DNA constructs comprising such optimised synthetic coding sequences for use in gene therapy of conditions caused by a deficiency in porphobilinogen deaminase, such as acute intermittent porphyria. Accordingly, the present invention relates to a nucleic acid or a nucleic acid construct comprising a nucleotide sequence coding for a human porphobilinogen deaminase, wherein at least 320 of the codons coding for the human porphobilinogen deaminase are identical to the codons in SEQ ID NO: 1 or wherein at least 305 of the codons coding for the human porphobilinogen deaminase are identical to the codons in SEQ ID NO: 3. | 10-27-2011 |
| 20120225933 | REGULATED EXPRESSION SYSTEMS - The application relates to gene constructs for inducible hepato-specific expression of polynucleotides of interest in response to an inducer agent, said constructs comprising (i) an inducible bi-directional operator-promoter with at least one responsive element to said inducer agent flanked by two hepato-specific promoters acting in divergent manner, (ii) a first nucleotide sequence encoding a transactivator which may be activated by said inducer agent operatively coupled to the first hepato-specific promoter and (iii) a second nucleotide sequence operatively coupled to the second hepato-specific promoter, wherein the promoters are induced as a consequence of the binding of the transactivator to the operator region of the operator-promoter in the presence of the inducer agent. | 09-06-2012 |
Gloria Huerta-Angeles, Ceska Trebova CZ
| Patent application number | Description | Published |
|---|---|---|
| 20120264913 | METHOD OF PREPARATION OF AN OXIDIZED DERIVATIVE OF HYALURONIC ACID AND A METHOD OF MODIFICATION THEREOF - The invention relates to a new method of preparation of a hyaluronan derivative with an aldehydic group in the position (6) of the polysaccharide glucosamine part. The hyaluronic acid oxidation can be performed by means of TEMPO/NaCIO or TEMPO/TCC systems in a protic environment with or without the presence of anorganic salts. Thus prepared aldehyde can be used for binding amines, diamines, amino acids, peptides and other compounds containing an amino group, e.g. by means of the reductive amination with NaBH | 10-18-2012 |
Gloria Menchi, Sesto Fiorentino IT
| Patent application number | Description | Published |
|---|---|---|
| 20130040964 | 1,2,3-TRIAZOLE-BASED PEPTIDOMIMETIC INTEGRIN INHIBITORS FOR THE DIAGNOSIS AND THERAPY OF TUMORS - The present invention refers to the field of chemical compounds bearing a 1,2,3-triazole ring of formula (I) and possessing guanidino and carboxylic groups or their isosteres, their preparation by Cu-catalyzed “click-chemistry”, and medical-diagnostic use in pathologies where angiogenesis is altered, for example pathologic conditions of tumor origin, tumor metastasis, osteoporosis, and rheumatoid arthritis. | 02-14-2013 |
Gloria Menchi, Sesto Florentino IT
| Patent application number | Description | Published |
|---|---|---|
| 20100087326 | HETEROCYLIC COMPOUNDS CONTAINING THE MORPHOLINE NUCLEUS THEIR PREPARATION AND USE - Herein are described heterocyclic compounds containing the morpholine nucleus prepared from amino acids, their preparation and use for therapeutic applications. | 04-08-2010 |
Gloria Montenegro Rizzardini, Santiago CL
| Patent application number | Description | Published |
|---|---|---|
| 20110076376 | NATURAL ANTIOXIDANT COMPOSITION FOR MEAT PRODUCTS PRODUCED FROM PHENOLIC EXTRACTS OF MONOFLORAL HONEYS, AND METHOD FOR OBTAINING THE SAME - Natural antioxidant composition for meat products, characterized in that it is prepared from phenolic extracts of monofloral honeys that act independently as antioxidants. | 03-31-2011 |
Gloria Rassu, Sassari IT
| Patent application number | Description | Published |
|---|---|---|
| 20100093612 | INTEGRIN TARGETED CYCLOPEPTIDE LIGANDS, THEIR PREPARATION AND USE - The present invention relates to novel hybrid cyclopeptide compounds embodying pyrrolidine- or piperidine-based amino acid substructures grafted onto a RGD (-Arg-Gly-Asp-) tripeptide sequence and acting as targeting ligands towards integrin receptors, intended, for example, for the treatment of altered angiogenic phenomena or for the preparation of therapeutically and/or diagnostically useful compounds; the invention also concerns a process for the synthesis of said cyclopeptides and biologically active derivatives thereof. | 04-15-2010 |
Gloria Restrepo Garces, Salon De Provence FR
| Patent application number | Description | Published |
|---|---|---|
| 20110168300 | MANUFACTURING METHOD FOR VERY HIGH-STRENGTH COLD-ROLLED DUAL-PHASE STEEL SHEETS AND SHEETS SO PRODUCED - The invention relates to a cold-rolled and annealed Dual-Phase steel sheet having a strength between 980 and 1100 MPa, and a breaking elongation greater than 9%, of which the composition comprises, the contents being expressed by weight: 0.055%≦C≦0.095%, 2%≦Mn≦2.6%, 0.005%≦Si≦0.35%, S≦0.005%, P≦0.050%, 0.1≦Al≦0.3%, 0.05%≦Mo≦0.25%, 0.2%≦Cr≦0.5%, it being understood that Cr+2Mo≦0.6%, Ni≦0.1%, 0.010≦Nb≦0.040%, 0.010≦Ti≦0.050%, 0.0005≦B≦0.0025%, and 0.002%≦N≦0.007%, the remainder of the composition consisting of iron and the inevitable impurities resulting from the smelting. | 07-14-2011 |
Gloria Sanclimens Perez De Rozas, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090298781 | COMPOUNDS FOR THE INHIBITION OF APOPTOSIS - The present invention relates to compounds of formula (I) as well as to drug conjugates based on compounds of formula (I) acting as apoptosis inhibitors, as well as to processes for their preparation, to pharmaceutical compositions containing them and their use in medicine. | 12-03-2009 |
Gloria Santacruz Rodriguez, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090241682 | Device for fixing of a prismatic mechanical test piece, method of utilization thereof and uses - A device for the fixing of a prismatic mechanical test piece, which consists of two mechanisms that secure the test piece ( | 10-01-2009 |
Gloria Shelby-Dyer, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120221238 | Clear sign rider - A clear sign rider. The novel clear sign rider is designed for attaching a secondary sign to a frame for holding a primary sign, and includes a sheet of transparent plastic folded over to form two parallel layers adapted to receive and hold the secondary sign therebetween, and a feature formed in the plastic for attaching the plastic to the frame. In an illustrative embodiment, the clear sign rider is adapted to be inserted in and fastened to a sign rider slot attached to the frame. At least one layer of the clear sign rider includes a hole for engaging a screw that attaches the layer to the slot. In a preferred embodiment, the clear sign rider also includes a circuit for wirelessly transmitting data to nearby mobile devices. | 08-30-2012 |
Gloria Sogan, Epagny FR
| Patent application number | Description | Published |
|---|---|---|
| 20090196714 | Device for the transport, storage, and transfer of substrates - According to the invention, a transport box ‘ | 08-06-2009 |
Gloria Stenfelt, Segeltorp SE
| Patent application number | Description | Published |
|---|---|---|
| 20120055949 | DECOY MATERIAL PACKAGE, A DISPENSER AND A METHOD FOR DISPENSING DECOY MATERIAL - A decoy material package and a dispenser. The package is intended for use in the dispenser. The package includes an elongated container including a strip, a plurality of depressions, which are to be filled with decoy material, and a cover, which is sealed to the container when the depressions have been filled with decoy material and which covers the container, whereby the decoy material is hermetically stored in the depressions of the package. A gripping portion cooperates with a feeder including a gripper in the decoy material dispenser. | 03-08-2012 |
Gloria Vendrell, Le Havre FR
| Patent application number | Description | Published |
|---|---|---|
| 20110263172 | MULTI-COMPONENT POLYOLEFIN ARTICLE COMPRISING HAVING A CONTROLLED DEGRADATION AND A PROCESS FOR THE PRODUCTION OF SAID ARTICLE - A multi-component article with controllable degradation and/or disintegration, comprising: | 10-27-2011 |
Gloria Vendrell, Bruxelles BE
| Patent application number | Description | Published |
|---|---|---|
| 20100016538 | POLYLACTIDE-URETHANE COPOLYMERS - A polylactide-urethane copolymer obtainable by a process, which comprises the step of contacting: | 01-21-2010 |
| 20100113734 | PROCESS FOR PRODUCING POLYLACTIDE-URETHANE COPOLYMERS - A process for producing polylactide-urethane copolymers, which comprises the step of contacting a polylactide having terminal hydroxyl groups, produced by contacting at least one lactide monomer with a diol or diamine, with a diisocyanate compound optionally in the presence of a second diol or diamine in the presence of a catalytic system under polymerisation conditions characterised in that the polylactide and the polylactide-urethane copolymers are produced by reactive extrusion. | 05-06-2010 |